EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing drug therapy in ostomy patients: Best practice recommendations for medication management

Vivien Berger iD, Matthias Reeh, Martin Scherer, Steffen Härterich, Sven Möller, Eva-Maria Anette Wansing, Annika van der Linde, Claudia Langebrake

PLOS ONE · 06.06.2024 · 19 (6) · e0305047

DOI: 10.1371/journal.pone.0305047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 06.06.2024. Verfasst von Vivien Berger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Pharmacists. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coloplast.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ostomy surgery is a common procedure that poses various challenges for patients and healthcare professionals. There are numerous guidelines addressing different ostomy-related problems (ORPs) and supporting an interdisciplinary approach for ostomy care, but evidence-based literature for optimizing drug therapy after ostomy surgery is lacking.

Aim

To investigate and characterize typical ORPs in relation to drug therapy and provide best practice recommendations from a pharmaceutical point of view.

Methods

Patients with an ileo- or colostomy were consecutively enrolled in a prospective, interventional monocentric cohort study during hospitalization, with particular attention to medication. A clinical pharmacist assessed DRPs by performing level 3 medication reviews and patient interviews. Pharmacists’ interventions (PIs) were evaluated by two senior clinical pharmacists and documented in DokuPIK (Documentation of Pharmacists’ Interventions in the Hospital). Following interdisciplinary discussions, physicians either accepted or rejected the proposed changes in drug therapy. Comparisons were made between ileostomy and colostomy patients regarding type and extent of PIs.

Results

Out of the 80 patients included in the cohort, 54 (67.5%) had an ileostomy and 26 (32.5%) a colostomy. In this study, 288 PIs were documented (234 ileostomy vs . 54 colostomy), of wich 94.0% were accepted and implemented by the physicians. The most common reason for PIs in both subgroups (29.6% ileostomy vs . 26.1% colostomy) was a missing drug although indicated (e.g. no loperamide, but high stoma output). The proportion of PIs associated with the ostomy was higher in ileostomy patients (48.3% ileostomy vs . 31.5% colostomy; p = 0.025). Typical ORPs were extracted and analyzed as case studies including recommendations for their respective management and prevention.

Conclusion

This study highlights the importance of clinical pharmacists being a part of interdisciplinary teams to collaboratively improve ostomy care and patient safety. Especially ileostomy patients are more vulnerable for ORPs in the context of drug therapy and need to be monitored carefully.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsHumansFemaleMaleAgedMiddle AgedProspective StudiesColostomyIleostomyAged, 80 and overMedication Therapy ManagementOstomyPractice Guidelines as TopicAdult

Autor:innen und Institutionen

  • Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of General, Abdominal, Thoracic and Vascular Surgery, Katholisches Marienkrankenhaus, Hamburg, Germany.
  • Department of General Practice and Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

ORCID-Profile: Vivien Berger

Förderung

  • Coloplast

Zitieren

APA

Berger, V., Reeh, M., Scherer, M., Härterich, S., Möller, S., Wansing, E. A., van der Linde, A., & Langebrake, C. (2024). Enhancing drug therapy in ostomy patients: Best practice recommendations for medication management. PLOS ONE, 19(6), e0305047. https://doi.org/10.1371/journal.pone.0305047

Vancouver

Berger V, Reeh M, Scherer M, Härterich S, Möller S, Wansing EA, et al. Enhancing drug therapy in ostomy patients: Best practice recommendations for medication management. PLOS ONE. 2024;19(6):e0305047. doi:10.1371/journal.pone.0305047

BibTeX
@article{Berger2024,
  author = {Berger, Vivien and Reeh, Matthias and Scherer, Martin and Härterich, Steffen and Möller, Sven and Wansing, Eva-Maria Anette and van der Linde, Annika and Langebrake, Claudia},
  title = {Enhancing drug therapy in ostomy patients: Best practice recommendations for medication management},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {6},
  pages = {e0305047},
  doi = {10.1371/journal.pone.0305047}
}
Kostenlos starten →